Market Overview:
The drug-resistant epilepsy market reached a value of US$ 3.6 Billion in 2023 and expected to reach US$ 6.0 Billion by 2034, exhibiting a growth rate (CAGR) of 4.76% during 2024-2034.
The drug-resistant epilepsy market report offers a comprehensive analysis of the market in the United States, EU5 (including Germany, Spain, Italy, France, and the United Kingdom), and...
English 
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek